Novo Nordisk Committed To Advancing In Cardiovascular
As Ziltivekimab Shows Promise
The Danish major’s head of development tells Scrip that as cardiovascular disease is very closely related to obesity and diabetes, Novo Nordisk has the expertise to thrive in the former.
